According to statistics released by the CFDA, as of April 22, 2016, a total of 28 pharmaceutical companies across the country had their GMP certificates withdrawn. Among them, 7 pharmaceutical companies were subject to unannounced inspections and their GMP certificates were withdrawn due to complaints from the public. For example, on April 5, the Guangdong Provincial Food and Drug Administration announced that Shenzhen Huayao Nanfang Pharmaceutical Co., Ltd. was subject to unannounced inspections due to complaints and reports. The company was warned for failing to implement the Good Manufacturing Practice for Drugs in accordance with regulations and was given a warning. Order the company to make corrections. For enterprises suspected of illegally organizing production, they will be handed over to the Provincial Bureau’s Inspection Branch for handling according to law.
Although the "withdrawal" incident made the industry feel very regretful and believed that it was the result of pharmaceutical companies "not knowing how to cherish it". However, compared with recall, many pharmaceutical companies are still working hard to pass GMP certification. According to incomplete statistics from Touhu.com, since February (as of February 2016), a total of 2 pharmaceutical companies across the country have obtained GMP certificates. Among them, there are as many as 5 in Zhejiang, 4 in Jiangxi, 2 in Shanxi, and 1 each in Tianjin and Hainan, but the overall "pass rate" is lower than the more than 100 in March.
Among the 13 GMP certificates issued, tablet companies are mostly , reaching 5, which are: Ningbo Tianzhen Pharmaceutical Co., Ltd., Jiangxi Rongyu Pharmaceutical Group Co., Ltd., Jiangxi Jinshikang Pharmaceutical Co., Ltd., Langzhi Group Wanrong Pharmaceutical Co., Ltd., Langzhi Group Wanrong Pharmaceutical Co., Ltd. lotion and Chinese herbal medicine tablets are the least, with only 1 pieces of each.
(Tian Zixia)
